Cite
HARVARD Citation
Kaishima, T. et al. (2018). Cost‐effectiveness analyses of anti‐hepatitis C virus treatments using quality of life scoring among patients with chronic liver disease in Hiroshima prefecture, Japan. Hepatology research. 48 (7), pp. 509-520. [Online].